Skip to content

Latest Post

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning
  • Sun. Nov 22nd, 2026
MedGadget.in logo – medical technology news and healthcare technology insights

  • Home
  • About Us
  • Author
  • Contact Us
Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…

Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb

A CDSCO expert panel recommended a Phase I trial of Indian Immunologicals' live attenuated Zika vaccine, developed with Griffith University and funded by ICMR.

Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb

PMV Pharmaceuticals' rezatapopt produced a 48% response rate in platinum-resistant ovarian cancer with TP53 Y220C in the pivotal PYNNACLE trial, with an FDA filing planned…

Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb

Mayo Clinic data from ObesityWeek 2026 show GLP-1 users with weakened hearts saw greater one-year gains in heart structure and function than matched non-users, with…

Healthcare Services

Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning

November 21, 2026 Simone Lamb

Up to 15 people have died and more than 300 have sought care in Imphal after drinking spurious liquor in Manipur's Chandel district. What we…

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn…

Uncategorized

Testosterone Prescriptions for Women Are Surging — So Are Pharmacy Denials and Delays

September 16, 2026 Simone Lamb

Testosterone prescriptions for women jumped 146% since 2023, but with no FDA-approved product for women, patients and doctors report a growing wave of pharmacy denials, dosing workarounds, high compounding costs,…

Uncategorized

UN Warns DR Congo’s Deadly Ebola Outbreak Still ‘Massive’ and Will Take Months to Fight

September 16, 2026 Simone Lamb

UN and WHO officials say the DR Congo Ebola outbreak, now the deadliest in the country's history with over 7,250 cases and 3,500 deaths, is improving in some regions but…

Uncategorized

Pennsylvania Reports Two Additional Measles-Associated Deaths as Outbreak Becomes Worst in Over 30 Years

September 16, 2026 Simone Lamb

Pennsylvania has confirmed two more measles-associated deaths, bringing the state's 2026 total to four, as nearly 700 cases and 133 hospitalizations mark its worst measles outbreak in more than three…

Uncategorized

China Sets World’s First AI Standard for Brain-Computer Interface Medical Devices

September 15, 2026 Simone Lamb

China's NMPA has approved its third BCI medical device standard, the world's first product guideline for AI-powered brain-computer interfaces, setting unified rules for brainwave data collection, processing, and storage ahead…

Uncategorized

Tempus AI’s Eric Lefkofsky: Why Healthcare Could Become AI’s Biggest Winner Yet

September 15, 2026 Simone Lamb

Tempus AI CEO Eric Lefkofsky told CNBC healthcare will likely be AI's biggest beneficiary, pointing to $1.5 trillion in wasted US healthcare spending and Tempus's own AI-driven genomics and cancer…

Uncategorized

WHO Chief Tedros Praises India’s Preventive Healthcare Push and Medical Product Regulation Efforts

September 15, 2026 Simone Lamb

WHO Director-General Tedros Adhanom Ghebreyesus praised India's primary healthcare expansion, ASHA workers, and efforts to strengthen medical product regulation during a meeting with Health Minister JP Nadda in Timor-Leste.

Uncategorized

South Korea’s Medical Tourism Boom: Why Millions of Foreign Patients Are Choosing Korean Healthcare

September 14, 2026 Simone Lamb

South Korea's foreign patient numbers jumped 71.7% to 2.01 million in 2025, as travelers increasingly add affordable, efficient health screenings to their trips. Here's how Korea is rising as a…

Uncategorized

Novo Holdings Backs China’s ForYou Medical in Push to Scale Global Advanced Wound Care Manufacturing

September 14, 2026 Simone Lamb

Novo Holdings has taken a minority stake in Huizhou ForYou Medical, a China-based wound care CDMO, betting on structural growth in advanced wound care manufacturing as chronic wound cases and…

Uncategorized

WHO Prequalifies Multi-Dose RSV Vaccine Vial, Paving the Way to Protecting More Infants Globally

September 14, 2026 Simone Lamb

WHO has prequalified a multi-dose vial of the maternal RSV vaccine RSVpreF, unlocking affordable, large-scale rollout in lower-income countries and clearing a Gavi-backed programme to protect infants from a leading…

Uncategorized

AI in Healthcare Market Poised to Rocket From $41.84B to $1.13 Trillion by 2035 as Generative AI Reshapes Global Care

September 12, 2026 Simone Lamb

New research shows the global AI in healthcare market growing from USD 41.84 billion in 2025 to USD 1,136.90 billion by 2035 at a 39.1% CAGR, led by generative AI,…

Posts pagination

1 … 34 35 36

You missed

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb
Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb
Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb
Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb
MedGadget.in logo – medical technology news and healthcare technology insights

Proudly powered by WordPress | Theme: NewsTwenty by Themeansar.

  • Home
  • About Us
  • Author
  • Contact Us